Razumab®(biosimilar ranibizumab) effectively improved the visual acuity and disease outcomes with no new safety concerns in patients with wet age-related macular degeneration in the real world setting.
Read More
Razumab® is effective in reducing macular thickness and improving visual acuity in patients with wet agerelated macular degeneration, diabetic macular edema, and retinal vein occlusion in routine clinical practice. Razumab® demonstrated considerable effectiveness with no new safety concerns.
Read More
Razumab® (biosimilar of ranibizumab) effectively improved visual acuity and disease outcomes in patients with RVO in a real-world setting with no new safety concerns.
Read More
The RE-ENACT 2 study further strengthens the data of biosimilar ranibizumab with improvements in visual acuity and disease outcomes observed for a longer follow-up duration up to 48 weeks in patients with wet age-related macular degeneration, diabetic macular edema, retinal vein occlusion and myopic choroidal neovascularization without any new safety issues.
Read More
Razumab (biosimilar ranibizumab) demonstrated improvements in visual acuity and disease outcomes in patients with wet age-related macular degeneration without new safety issues.
Read More
Biosimilar ranibizumab demonstrated improvements in visual acuity and disease outcomes up to 48 weeks in patients with RVO without any new safety concerns.
Read More
Corporate House, Near Sola Bridge, S.G. Highway, Thaltej, Ahmedabad-380054, Gujarat, INDIA.
MEDICAL DISCLAIMER
All content found on the razumab.co.in website, including: text, images, audio, or other formats were created for informational purposes only. Offerings for continuing education credits are clearly identified and the appropriate target audience is identified. The content is not intended or meant to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 102 immediately. razumab.co.in does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on razumab.co.in. Reliance on any information provided by razumab.co.in, employees, contracted writers, or medical professionals presenting content for publication to razumab.co.in is solely at your own risk. The site may contain health- or medical-related materials or discussions regarding Eye diseases. If you find these materials offensive, you may not want to use our Site. The Site and its Content are provided on an "as is" basis. Links to educational content not created by razumab.co.in are taken or accessed at your own risk. razumab.co.in is not responsible for the claims of external websites and education companies.
Disclaimer: User data will be collected for better functionality and user response and data included in the chatbot will be kept confidential and will not be shared elsewhere.
